Stage IIIB Non-Small Cell Lung Cancer

DBCOND0029968Lung DiseasesThoracic and Respiratory Tract Neoplasms

Stage IIIB Non-Small Cell Lung Cancer is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
NSCLC Stage IIIB · Non-Small Cell Lung Cancer Stage IIIB · Non Small Cell Lung Cancer Stage 3 (III)B
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10025054UMLSC0278984

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
161Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Stage IIIB Non-Small Cell Lung Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In